Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial
- PMID: 34951063
- PMCID: PMC9306840
- DOI: 10.1002/ana.26291
Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial
Abstract
Objective: Randomized clinical trials have shown that aerobic exercise attenuates motor symptom progression in Parkinson's disease, but the underlying neural mechanisms are unclear. Here, we investigated how aerobic exercise influences disease-related functional and structural changes in the corticostriatal sensorimotor network, which is involved in the emergence of motor deficits in Parkinson's disease. Additionally, we explored effects of aerobic exercise on tissue integrity of the substantia nigra, and on behavioral and cerebral indices of cognitive control.
Methods: The Park-in-Shape trial is a single-center, double-blind randomized controlled trial in 130 Parkinson's disease patients who were randomly assigned (1:1 ratio) to aerobic exercise (stationary home trainer) or stretching (active control) interventions (duration = 6 months). An unselected subset from this trial (exercise, n = 25; stretching, n = 31) underwent resting-state functional and structural magnetic resonance imaging (MRI), and an oculomotor cognitive control task (pro- and antisaccades), at baseline and at 6-month follow-up.
Results: Aerobic exercise, but not stretching, led to increased functional connectivity of the anterior putamen with the sensorimotor cortex relative to the posterior putamen. Behaviorally, aerobic exercise also improved cognitive control. Furthermore, aerobic exercise increased functional connectivity in the right frontoparietal network, proportionally to fitness improvements, and it reduced global brain atrophy.
Interpretation: MRI, clinical, and behavioral results converge toward the conclusion that aerobic exercise stabilizes disease progression in the corticostriatal sensorimotor network and enhances cognitive performance. ANN NEUROL 2022;91:203-216.
© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
Nothing to report.
Figures
Comment in
-
Novel biomarkers and neuroimaging techniques in Parkinson's disease.J Neurol. 2024 Feb;271(2):1056-1058. doi: 10.1007/s00415-024-12187-6. Epub 2024 Jan 17. J Neurol. 2024. PMID: 38231269 Free PMC article. No abstract available.
References
-
- van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home‐based and remotely supervised aerobic exercise in Parkinson's disease: a double‐blind, randomised controlled trial. Lancet Neurol 2019;4422:1–11. - PubMed
-
- Cools R. Dopaminergic modulation of cognitive function‐implications for L‐DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1–23. - PubMed
-
- Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:876–880. - PubMed
